An integrin-activating peptide, PHSRN, ameliorates inhibitory effects of conventional peritoneal dialysis fluids on peritoneal wound healing

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1109-1119

  Miyamoto, Tetsu ^a   Tamura, Masahito ^b   Kabashima, Narutoshi ^b   Serino, Ryota ^a   Shibata, Tatsuya ^b   Furuno, Yumi ^a   Miyazaki, Mieko ^a   Baba, Ryoko ^a   Sato, Nagahiro ^a   Doi, Yoshiaki ^a   Okazaki, Masahiro ^a   Otsuji, Yutaka ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b School of Medicine   (Japan)

Author keywords

Focal adhesion kinase; Integrins; Peritoneal dialysis; PHSRN; Wound healing

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; CD68 ANTIGEN; CRK ASSOCIATED SUBSTRATE PROTEIN; CYTOKERATIN; FIBRONECTIN; FOCAL ADHESION KINASE; GLUCOSE; HBME 1 MONOCLONAL ANTIBODY; INTEGRIN; MONOCLONAL ANTIBODY; PEPTIDE; PERITONEAL DIALYSIS FLUID; PROLYLHISTIDYLSERYLARGINYLASPARAGINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL MOTILITY; CONTROL GROUP; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; ENZYME PHOSPHORYLATION; FEMALE; FIBROBLAST; KIDNEY CELL; MESOTHELIUM; MESOTHELIUM CELL; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEUM; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; REGENERATION; WOUND HEALING;

ANIMALS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; FEMALE; FIBRONECTINS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTEGRINS; PEPTIDE FRAGMENTS; PERITONEAL DIALYSIS; PERITONEUM; RATS; RATS, WISTAR; WOUND HEALING;

EID: 77950215890     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp601     Document Type: Article

References (43)

1. Topley N. Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions. Adv Renal Replace Ther 1998; 5: 179-184
2. Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Ne-phrol 2002; 13: 470-479
3. Williams JD, Craig KJ, von Ruhland C, et al. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; S43-S49
4. Heimburger O, Waniewski J, Werynski A, et al. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38: 495-506
5. Brulez HF, Verbrugh HA. First-line defense mechanisms in the peritoneal cavity during peritoneal dialysis. Perit Dial Int 1995; 15: S24-S33
6. Betjes MG, Bos HJ, Krediet RT. The mesothelial cells in CAPD effluent and their relation to peritonitis incidence. Perit Dial Int 1991; 11: 22-26
7. Leavesley DI, Stanley JM, Faull RJ. Epidermal growth factor modifies the expression and function of extracellular matrix adhesion receptors expressed by peritoneal mesothelial cells from patients on CAPD. Nephrol Dial Transplant 1999; 14: 1208-1216
8. Dobbie JW, Lloyd JK, Gall CA. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. Adv Perit Dial 1990; 6: 3-12
9. Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 1999; 55: 341-356
10. Ito T, Yorioka N, Yamamoto M. Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. J Am Soc Nephrol 2000; 11: 1969-1979
11. Tamura M, Osajima A, Nakayamada S, et al. High glucose levels inhibit focal adhesion kinase-mediated wound healing of rat peritoneal mesothelial cells. Kidney Int 2003; 63: 722-731
12. del Peso G, Fernandez-Reyes MJ, Hevia C, et al. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor. Nephrol Dial Transplant 2005; 20: 1201-1206
13. Davies SJ, Bryan J, Phillips L, et al. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498-506
14. Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol 2001; 189: 1-13
15. Akiyama SK. Integrins in cell adhesion and signaling. Hum Cell 1996; 9: 181-186
16. Kim JP, Zhang K, Chen JD. Mechanism of human keratinocyte migration on fibronectin: unique roles of RGD site and integrins. J Cell Physiol 1992; 151: 443-450
17. Aota S, Nomizu M, Yamada KM. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 1994; 269: 24756-24761
18. Yamada KM. Fibronectin peptides in cell migration and wound repair. J Clin Invest 2000; 105: 1507-1509
19. Feng Y, Mrksich M. The synergy peptide PHSRN and the adhesion peptide RGD mediate cell adhesion through a common mechanism. Biochemistry 2004; 43: 15811-15821
20. Ochsenhirt SE, Kokkoli E, McCarthy JB, et al. Effect of RGD secondary structure and the synergy site PHSRN on cell adhesion, spreading and specific integrin engagement. Biomaterials 2006; 27: 3863-3874
21. Ross JA, Ansell I, Hjelle JT. Phenotypic mapping of human mesothe-lial cells. Adv Perit Dial 1998; 14: 25-30
22. Huhtala P, Humphries MJ, McCarthy JB, et al. Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metallopro-teinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995; 129: 867-879
23. Livant DL, Brabec RK, Kurachi K, et al. The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest 2000; 105: 1537-1545
24. Kimura K, Hattori A, Usui Y, et al. Stimulation of corneal epithelial migration by a synthetic peptide (PHSRN) corresponding to the second cell-binding site of fibronectin. Investig Ophthalmol Vis Sci 2007; 48: 1110-1118
25. Ko JA, Yanai R, Quan WY, et al. Up-regulation of HSP70 by the fi-bronectin-derived peptide PHSRN in human corneal epithelial cells. Biochem Biophys Res Commun 2008; 370: 424-428
26. Tamura M, Gu J, Matsumoto K. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998; 280: 1614-1617
27. Tamura M, Gu J, Takino T, et al. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res 1999; 59: 442-449
28. Matsuo H, Tamura M, Kabashima N. Prednisolone inhibits hyperos-molarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells. Kidney Int 2006; 69: 736-746
29. Clark RAF. Wound repair: overview and general considerations. In: RAF Clark (ed). The Molecular and Cellular Biology of Wound Repair. 2nd edition. New York, USA: Plenum Press, 1996; 3-50
30. Desmouliere A, Redard M, Darby I, et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995; 146: 56-66
31. Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int 2000; 58: 1953-1962
32. Ilic D, Furuta Y, Kanazawa S. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995; 377: 539-544
33. Cohen LA, Guan JL. Mechanisms of focal adhesion kinase regulation. Curr Cancer Drug Targets 2005; 5: 629-643
34. Cary LA, Han DC, Polte TR, et al. Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J Cell Biol 1998; 140: 211-221
35. Defilippi P, Di Stefano P, Cabodi S. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 2006; 16: 257-263
36. Gu J, Tamura M, Pankov R. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 1999; 146: 389-403
37. Imai H, Nakamoto H, Fukushima R, et al. Role of adhesion molecules in the progression of peritoneal sclerosis. Adv Perit Dial 2003; 19: 180-185
38. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005; 13: 7-12
39. Desmouliere A, Darby IA, Gabbiani G. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 2003; 83: 1689-1707
40. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413
41. Del Peso G, Jimenez-Heffernan JA, Bajo MA, et al. Epithelial-to- mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney Int Suppl 2008; S26-S33
42. Shui HA, Ka SM, Lin JC, et al. Fibronectin in blood invokes the development of focal segmental glomerulosclerosis in mouse model. Nephrol Dial Transplant 2006; 21: 1794-1802
43. Sobel RA, Mitchell ME. Fibronectin in multiple sclerosis lesions. Am J Pathol 1989; 135: 161-168